Results 291 to 300 of about 200,218 (362)

Long‐Term Stability of Spatial Distribution and Peak Dynamics of Subthalamic Beta Power in Parkinson's Disease Patients

Movement Disorders, EarlyView.
Abstract Background Subthalamic beta oscillations are a biomarker for bradykinesia and rigidity in Parkinson's disease (PD), incorporated as a feedback signal in adaptive deep brain stimulation with potential for guiding electrode contact selection.
Jennifer K. Behnke, Robert L. Peach, Jeroen G.V. Habets, Johannes L. Busch, Jonathan Kaplan, Jan Roediger, Varvara Mathiopoulou, Lucia K. Feldmann, Moritz Gerster, Juliette Vivien, Gerd‐Helge Schneider, Katharina Faust, Patricia Krause, Andrea A. Kühn   +13 more
wiley   +1 more source

Subcutaneous Foslevodopa as Novel Rescue Therapy for Akinetic Crisis in Parkinson's Disease: A Case Report

Movement Disorders Clinical Practice, EarlyView.
Bendix Labeit, Julius Schulten, Alfons Schnitzler, Christian Johannes Hartmann   +3 more
wiley   +1 more source

Treatment Efficacy of Theophylline in ADCY5‐Related Dyskinesia: A Retrospective Case Series Study

Movement Disorders, EarlyView.
Abstract Background ADCY5‐related dyskinesia is a rare disorder caused by mutations in the ADCY5 gene resulting in abnormal involuntary movements. Currently, there are no standardized guidelines to treat this condition. Objective The aim of this study was to evaluate the efficacy of theophylline administration in improving symptoms and quality of life ...
Dirk Taenzler, Frank Hause, Andreas Merkenschlager, Andrea Sinz   +3 more
wiley   +1 more source

B(RAIN)²-BRAIN integrated Resource for Anatomy and Intracranial Neurophysiology. [PDF]

Sci Data
Alijanpourotaghsara A, Mirpour K, Choi JW, Chitta KK, Shalaby A, Boswell M, Chilukuri S, Cohen SL, Byon R, Benam M, Kariv S, Lee J, Duncan D, Pouratian N.   +13 more
europepmc   +1 more source

Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Motor cortex disinhibition, as measured by impaired short‐interval intracortical inhibition (SICI) using transcranial magnetic stimulation (TMS), is a well‐established feature of Parkinson's disease (PD). However, its substantial variability among patients remains unexplained, prompting questions about its origin, clinical relevance,
Claudia Ammann, Cristina Pagge, Emmanuelle Wilhelm, Chiara Galletti, Tamara Jimenez‐Castellanos, Michele Matarazzo, Agustina Ruiz‐Yanzi, Carmen Gasca‐Salas, Raul Martínez‐Fernández, Fernando Alonso‐Frech, Antonio Oliviero, José A. Obeso, Guglielmo Foffani   +12 more
wiley   +1 more source

Correction to: Peripheral signaling pathways contributing to non-histaminergic itch in humans. [PDF]

J Transl Med
Fiebig A, Leibl V, Oostendorf D, Lukaschek S, Frömbgen J, Masoudi M, Kremer AE, Strupf M, Reeh P, Düll M, Namer B.   +10 more
europepmc   +1 more source

GQ1b-Positive Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome Presenting With Pseudoathetosis and Pseudodystonia in a 47-Year-Old Filipino Female: A Case Report. [PDF]

Cureus
Go CLD, Dy JSH, Rosales RL.
europepmc   +1 more source

Erratum: Chakravarty et al., "Transient Response of Basal Ganglia Network in Healthy and Low-Dopamine State". [PDF]

eNeuro
europepmc   +1 more source

Erratum: Cheng et al., "Representational Geometries Reveal Differential Effects of Response Correlations on Population Codes in Neurophysiology and Functional Magnetic Resonance Imaging". [PDF]

J Neurosci
europepmc   +1 more source